Dennis Schrijnders - Publications

Glycemic Control for Colorectal Cancer Survivors Compared to Those without Cancer in the Dutch Primary Care for Type 2 Diabetes: A Prospective Cohort Study.

Journal: Cancers

Published: April 27, 2021

Is Gliclazide Associated with a Lower Obesity-Related Cancer Risk Compared to Other Sulfonylureas? A Long-term Prospective Cohort Study.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: December 09, 2019

Sulfonylurea derivatives and cancer, friend or foe?

Journal: European journal of pharmacology

Published: April 18, 2019

Association between body mass index and obesity-related cancer risk in men and women with type 2 diabetes in primary care in the Netherlands: a cohort study (ZODIAC-56).

Journal: BMJ open

Published: January 27, 2018

Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49).

Journal: PloS one

Published: August 11, 2017

Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) - a study protocol.

Journal: BMC cancer

Published: April 11, 2017

Is orthostatic hypotension related to falling? A meta-analysis of individual patient data of prospective observational studies.

Journal: Age and ageing

Published: August 29, 2016

Within-Sulfonylurea-Class Evaluation of Time to Intensification with Insulin (ZODIAC-43).

Journal: PloS one

Published: February 26, 2016

Addition of sulphonylurea to metformin does not relevantly change body weight: a prospective observational cohort study (ZODIAC-39).

Journal: Diabetes, obesity & metabolism

Published: February 10, 2016

Comment on Genuth. Should sulfonylureas remain an acceptable first-line add-on to metformin therapy in patients with type 2 diabetes? No, it's time to move on! Diabetes Care 2015;38:170-175.

Journal: Diabetes care

Published: May 23, 2015

Within-class differences of the sulfonylureas should be accounted for.

Journal: Diabetologia

Published: February 11, 2015

Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.

Journal: Endoscopy

Published: April 13, 2013